Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

European Respiratory Society guidelines for the diagnosis of asthma in adults

R Louis, I Satia, I Ojanguren, F Schleich… - European …, 2022 - Eur Respiratory Soc
Although asthma is very common, affecting 5–10% of the population, the diagnosis of
asthma in adults remains a challenge in the real world, which results in both over-and under …

Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline

CL Rochester, JA Alison, B Carlin… - American journal of …, 2023 - atsjournals.org
Background: Despite the known benefits of pulmonary rehabilitation (PR) for patients with
chronic respiratory disease, this treatment is underused. Evidence-based guidelines should …

[HTML][HTML] Goals of COPD treatment: Focus on symptoms and exacerbations

CF Vogelmeier, M Roman-Rodriguez, D Singh… - Respiratory …, 2020 - Elsevier
Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD …

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report

VM McDonald, J Fingleton, A Agusti… - European …, 2019 - publications.ersnet.org
“Treatable traits” have been proposed as a new paradigm for the management of airway
diseases, particularly complex disease, which aims to apply personalised medicine to each …

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma

H Breiteneder, YQ Peng, I Agache, Z Diamant… - Allergy, 2020 - Wiley Online Library
Modern health care requires a proactive and individualized response to diseases,
combining precision diagnosis and personalized treatment. Accordingly, the approach to …

COPD 2020: changes and challenges

A Agustí, C Vogelmeier… - American Journal of …, 2020 - journals.physiology.org
3 Chronic obstructive pulmonary disease (COPD) is a major global health problem due to 26
its high prevalence (about 10% of the adult population), raising incidence (related in 27 part …

Bronchiectasis

JD Chalmers, AB Chang, SH Chotirmall… - Nature reviews Disease …, 2018 - nature.com
Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …

The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease

AJ Dicker, JTJ Huang, M Lonergan, HR Keir… - Journal of Allergy and …, 2021 - Elsevier
Background The sputum microbiome has a potential role in disease phenoty** and risk
stratification in chronic obstructive pulmonary disease (COPD), but few large longitudinal …

[CITATION][C] Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

D Singh, A Agusti, A Anzueto, PJ Barnes… - European …, 2019 - Eur Respiratory Soc